Earnings Ahead

JNJ - Johnson

202.48 -2.85 -1.39

Johnson

Johnson

About

Profile

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices.


Headquarters

New Brunswick, New Jersey, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

JNJ



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Johnson & Johnson raises 2025 sales guidance by $2B and targets $50B oncology sales by 2030 amid robust Q2 performance
  • J&J rallies big pharma after earnings despite Trump’s latest tariff threat
  • 4 stocks to watch on Wednesday: GS, MS, JNJ, BAC
  • J&J boosts full-year outlook on forex tailwinds and operational performance
  • Earnings Snapshot: Johnson & Johnson surpasses Q2 estimates; raises FY25 outlook above consensus
  • Johnson & Johnson's Charts: Innovative Medicine +5% Y/Y in Q2 led by 23% rise in DARZALEX
  • Johnson & Johnson declares $1.30 dividend
  • Johnson & Johnson Non-GAAP EPS of $2.77 beats by $0.09, revenue of $23.7B beats by $840M
  • Trump eyes drug, chip tariffs by month-end
  • Johnson & Johnson Q2 Preview: Focus on tariff threat, MedTech softness
  • Short bets against S&P 500 healthcare stocks climb in June; MRNA tops list again
  • Earnings week ahead: JPM, BAC, GS, MS, C, JNJ, TSM, ABT, PEP, MMM, SLB, UAL, NFLX, and more
  • FDA mulls faster drug reviews in exchange for lower prices in U.S.- Bloomberg
  • FDA publishes more than 200 rejection letters in a bid to improve transparency
  • J&J wins appeals court ruling against Teva and Viatris in patent dispute over neuro drug
  • Trump mulls 200% tariff on pharmaceuticals
  • Johnson & Johnson seeks FDA nod for expanded use of Caplyta
  • Leaked memo reportedly shows biotech lobby group’s opposition to RFK Jr.
  • US judge halts Trump administration move to layoff HHS employees
  • Bristol Myers, Gilead, J&J, Novartis win favorable FDA label updates for cell therapies

Earnings History

Date EPS / Forecast Revenue / Forecast
January 25, 2022 2.13 / 2.12 24.8B / 25.28B
October 19, 2021 2.6 / 2.35 23.34B / 23.64B
July 21, 2021 2.48 / 2.29 23.31B / 22.49B Beat!
April 20, 2021 2.59 / 2.34 22.32B / 21.98B Beat!
January 26, 2021 1.86 / 1.82 22.48B / 21.66B Beat!
October 13, 2020 2.2 / 1.98 21.08B / 20.2B Beat!
July 16, 2020 1.67 / 1.49 18.34B / 17.61B Beat!
April 14, 2020 2.3 / 2.02 20.69B / 19.73B Beat!
January 22, 2020 1.88 / 1.87 20.75B / 20.8B
October 15, 2019 2.12 / 2.01 20.73B / 20.08B Beat!
July 16, 2019 2.58 / 2.46 20.56B / 20.29B Beat!
April 16, 2019 2.1 / 2.04 20.02B / 19.61B Beat!
January 22, 2019 1.97 / 1.95 20.39B / 20.2B Beat!
October 16, 2018 2.05 / 2.03 20.35B / 20.05B Beat!
July 17, 2018 2.1 / 2.07 20.83B / 20.42B Beat!
April 17, 2018 2.06 / 2 20.01B / 19.49B Beat!
January 23, 2018 1.74 / 1.72 20.2B / 20,072M
October 17, 2017 1.9 / 1.80 19.65B / 19,283M
July 18, 2017 1.83 / 1.80 18.84B / 18,935M
April 18, 2017 1.83 / 1.77 17.77B / 18,037M
Date Price Open High Low Vol Change
Dec 4 202.48 204.59
204.73
201.73
8.6M -1.39%
Dec 3 205.33 205.9
207.02
204.99
8.4M -0.04%
Dec 2 205.42 205.24
205.61
203.1
8.4M 0.04%
Dec 1 205.34 206.5
207.7
205.34
8.5M -0.76%
Nov 28 206.92 207
207.46
204.63
5.6M -0.31%
 
Nov 26 207.56 206.49
207.81
205.94
6.7M 0.43%
Nov 25 206.67 205.18
207.72
205.18
10.3M 0.30%
Nov 24 206.05 203.71
206.12
203
14.8M 1.05%
Nov 21 203.9 203.96
206.94
202.99
13.2M 0.41%
Nov 20 203.07 202
204.51
201.57
10.6M 0.28%
Nov 19 202.51 200
203.48
199.38
14.7M 1.26%
Nov 18 200 199.01
200.3
198.53
12.5M 0.21%
Nov 17 199.58 196.96
200.27
195.9
13.3M 1.86%
Nov 14 195.93 195
197.18
193.55
8.8M 0.35%
Nov 13 195.25 194.21
196
193.45
8.6M 0.44%
Nov 12 194.39 193.36
195.54
193.07
8.8M 0.29%
Nov 11 193.83 189.38
193.92
189.05
7.5M 2.88%
Nov 10 188.41 186
188.42
185.12
5.3M 0.99%
Nov 7 186.57 187.74
188.35
185.7
7.0M -0.21%
Nov 6 186.97 186.76
187.52
185.37
6.8M 0.52%
Nov 5 186 186.64
187.83
185.4
5.0M -0.46%
Nov 4 186.86 186.83
187.82
185.62
7.2M 0.32%
Nov 3 186.26 189
189.03
185.52
7.5M -1.38%
Oct 31 188.87 187.46
189.5
186.76
8.8M -0.1%
Oct 30 189.05 187.08
189.38
186.91
7.1M 1.31%
Oct 29 186.6 186.7
187.1
184.66
10.6M -0.18%
Oct 28 186.93 189.26
189.51
186.62
8.3M -1.77%
Oct 27 190.3 189.99
190.8
189.53
7.1M -0.05%
Oct 24 190.4 192.2
192.31
189.42
6.9M -1.08%
Oct 23 192.47 192.56
194
191.54
8.9M -0.24%
Oct 22 192.94 192
193.45
191.77
6.3M 0.55%
Oct 21 191.88 193.01
193.55
191.77
6.7M -0.95%
Oct 20 193.72 193.5
194.48
192.33
8.0M 0.26%
Oct 17 193.22 192.5
193.6
191.68
7.8M 0.57%
Oct 16 192.12 191.34
193.05
190.43
10.6M 0.50%
Oct 15 191.17 191.48
193.57
189.3
9.5M 0.17%
Oct 14 190.85 192.92
194.4
185.88
13.6M -0.03%
Oct 13 190.9 189.83
191.3
189.28
8.0M 0.09%
Oct 10 190.72 192.01
192.07
189.85
9.6M -0.19%
Oct 9 191.08 190
192.1
189.73
7.5M 0.73%
Oct 8 189.69 188.87
190.21
188.27
5.8M 0.42%
Oct 7 188.89 183.77
189.23
182.94
8.8M 0.39%
Oct 6 188.16 188
189.92
187.37
5.8M -0.25%
Oct 3 188.64 187.06
189.78
186.91
8.7M 1.43%
Oct 2 185.98 184.19
186.59
184.09
7.7M -0.04%
Oct 1 186.05 186
186.56
183.91
13.1M 0.34%
Sep 30 185.42 181.7
185.99
181.07
11.6M 2.09%
Sep 29 181.62 179.82
181.87
179.8
8.6M 1.06%
Sep 26 179.71 178.6
179.91
177.32
8.6M 1.11%
Sep 25 177.73 177.2
178.4
175.91
8.5M 0.59%
Sep 24 176.69 176.14
176.95
175.74
6.7M 0.06%
Sep 23 176.58 174.89
176.97
174.83
8.4M 1.36%
Sep 22 174.21 176.09
176.64
174.12
7.2M -1.12%
Sep 19 176.19 174.69
177.16
173.33
25.6M 1.17%
Sep 18 174.16 176.6
177.02
173.87
8.2M -1.72%
Sep 17 177.2 176.71
178.51
176.59
6.7M 0.42%
Sep 16 176.46 177.57
177.62
175.65
8.0M -0.53%
Sep 15 177.4 177.76
178.99
176.93
4.8M -0.37%
Sep 12 178.06 177.71
178.8
176.72
7.2M -0.25%
Sep 11 178.5 175.75
178.85
175.63
5.8M 0%